Bayer sells HC Starck to private equity for €1.2bn

23 November 2006 15:13  [Source: ICIS news]

H C Starck sold to private equityLONDON (ICIS news)--Bayer said on Thursday it would sell its metals and powders company H C Starck to Advent International and the Carlyle Group for €1.2bn ($1.6bn).

The financial investors said they aimed for an initial public offering for the Goslar, Germany, producer within three to five years.

Advent and Carlyle will pay €700m in cash for H C Starck and assume personnel-related and financial liabilities of some €450m.

Bayer said the divestment would cut its net debt by about €1bn and lead to an accounting gain of €150m. Closing was expected at the beginning of 2007.

 “It [H C Starck] not only holds leadership positions in its markets, but also has enormous growth potential in existing and prospective new business areas,” said Advent International’s general manager in Frankfurt, Ralf Huep.

H C Starck makes metal and ceramic powders, specialty chemicals and components made from advanced materials and refractory powders.

It had sales in 2005 of €920m.

Bayer had held an auction for H C Starck in which buyers were able to examine the company in detail and submit a binding offer. The process had attracted both strategic and financial investors, it said.

In March the drugs to chemicals group said it aimed to agree the sale of H C Starck and the cellulosics producer Wolff Walsrode, both part of Bayer MaterialScience, in 2006 to partly finance its €17bn acquisition of compatriot drugs maker Schering. 

German press reports in September named Akzo Nobel, Dow Chemical, Shin-Etsu, JM Huber and Hercules as parties interested in Wolff Walsrode but suggested that private equity was not in the race. Wolff Walsrode had 2005 sales of €329m.


By: Nigel Davis
+44 20 8652 3214



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly

ICIS news FREE TRIAL
Get access to breaking chemical news as it happens.
ICIS Global Petrochemical Index (IPEX)
ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index